GCM aims to give the market open, satisfactory information about the company’s operations, strategy and results with a view to ensuring fair pricing of the share and to contribute to ensuring good corporate governance.

GCM is dedicated to developing novel technologies that bring greater efficiency and convenience to research laboratories in the proteomic and biotechnology areas. GCM's flagship Proteotyper kits are primarily targeted at supporting our customers worldwide with high-quality consumables, accessories and kits specifically produced for the Human Proteome Project.

Parties interested in an equity investment in GCM, or in licensing or acquiring rights within the product portfolio, please, get contact.